GHAM
Gilman Hill Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.84M | Buy |
5,415
+112
| +2% | +$58.8K | 0.46% | 75 |
|
|
2025
Q1 | $3.36M | Buy |
5,303
+100
| +2% | +$63.4K | 0.58% | 68 |
|
|
2024
Q4 | $3.71M | Buy |
5,203
+58
| +1% | +$41.3K | 0.65% | 60 |
|
|
2024
Q3 | $5.41M | Buy |
5,145
+22
| +0.4% | +$23.1K | 0.9% | 40 |
|
|
2024
Q2 | $5.38M | Buy |
5,123
+231
| +5% | +$243K | 0.97% | 34 |
|
|
2024
Q1 | $4.71M | Sell |
4,892
-15
| -0.3% | -$14.4K | 0.84% | 38 |
|
|
2023
Q4 | $4.31M | Sell |
4,907
-187
| -4% | -$164K | 0.8% | 45 |
|
|
2023
Q3 | $4.19M | Sell |
5,094
-927
| -15% | -$763K | 0.82% | 44 |
|
|
2023
Q2 | $4.33M | Buy |
6,021
+285
| +5% | +$205K | 0.81% | 45 |
|
|
2023
Q1 | $4.71M | Buy |
5,736
+187
| +3% | +$154K | 0.96% | 38 |
|
|
2022
Q4 | $4M | Buy |
5,549
+72
| +1% | +$51.9K | 0.82% | 45 |
|
|
2022
Q3 | $3.77M | Buy |
5,477
+549
| +11% | +$378K | 0.88% | 38 |
|
|
2022
Q2 | $2.91M | Buy |
4,928
+554
| +13% | +$327K | 0.63% | 48 |
|
|
2022
Q1 | $3.06M | Sell |
4,374
-55
| -1% | -$38.4K | 0.7% | 43 |
|
|
2021
Q4 | $2.8M | Buy |
4,429
+222
| +5% | +$140K | 0.62% | 43 |
|
|
2021
Q3 | $2.55M | Buy |
4,207
+248
| +6% | +$150K | 0.65% | 45 |
|
|
2021
Q2 | $2.21M | Buy |
3,959
+108
| +3% | +$60.3K | 0.57% | 55 |
|
|
2021
Q1 | $1.82M | Buy |
+3,851
| New | +$1.82M | 0.5% | 57 |
|
|
2019
Q2 | – | Sell |
-500
| Closed | -$205K | – | 192 |
|
|
2019
Q1 | $205K | Buy |
+500
| New | +$205K | 0.07% | 172 |
|
|
2018
Q4 | – | Sell |
-525
| Closed | -$212K | – | 186 |
|
|
2018
Q3 | $212K | Buy |
+525
| New | +$212K | 0.08% | 161 |
|